Masaya Tanno Selected Research

Antioxidants

1/2019	Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats.
9/2011	Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masaya Tanno Research Topics

Disease

27	Infarction (Infarctions) 01/2018 - 07/2002
21	Ischemia 01/2018 - 07/2002
10	Type 2 Diabetes Mellitus (MODY) 01/2023 - 12/2009
8	Necrosis 02/2021 - 06/2010
7	Myocardial Infarction 01/2020 - 04/2006
6	Heart Failure 03/2023 - 03/2010
5	Reperfusion Injury 02/2021 - 11/2007
5	Fibrosis (Cirrhosis) 02/2016 - 03/2010
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 08/2003
3	Cardiomyopathies (Cardiomyopathy) 02/2016 - 02/2013
2	Hyperglycemia 06/2021 - 01/2020
2	Left Ventricular Dysfunction 01/2021 - 01/2012
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 12/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2017
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 02/2016 - 03/2010
2	Muscular Dystrophies (Muscular Dystrophy) 08/2015 - 09/2011
2	Cardiomegaly (Heart Hypertrophy) 08/2015 - 02/2013
2	Hypertrophy 02/2013 - 01/2011
2	Ventricular Remodeling 04/2006 - 05/2003
1	Diabetic Cardiomyopathies 02/2024
1	Infections 06/2021
1	Hypoglycemia (Reactive Hypoglycemia) 06/2021
1	Oliguria 02/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Insulin Resistance 01/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2021
1	Ventricular Dysfunction 01/2021
1	Neoplasms (Cancer) 12/2019
1	Cardio-Renal Syndrome 07/2019
1	Diabetes Mellitus 07/2019

Drug/Important Bio-Agent (IBA)

8	Erythropoietin FDA Link 12/2012 - 04/2006
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2011
6	salicylhydroxamic acid (SHAM)IBA 01/2018 - 05/2003
5	Adenosine Triphosphate (ATP)IBA 01/2018 - 07/2002
5	Mitochondrial Permeability Transition PoreIBA 01/2018 - 11/2007
5	Sirtuin 1IBA 08/2015 - 03/2010
5	Glycogen Synthase Kinase 3 betaIBA 10/2010 - 08/2006
5	SB 203580IBA 09/2009 - 08/2003
4	ResveratrolIBA 08/2015 - 03/2010
4	Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA 06/2012 - 09/2006
4	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 05/2012 - 12/2009
4	Protein Kinases (Protein Kinase)IBA 12/2010 - 10/2006
4	Protein Kinase C-epsilonIBA 02/2009 - 07/2002
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 10/2006
3	AMP Deaminase (Myoadenylate Deaminase)IBA 02/2024 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 07/2019
3	empagliflozinIBA 01/2020 - 01/2018
3	Sodium-Glucose Transporter 2 InhibitorsIBA 07/2019 - 01/2018
3	Dihydrotachysterol (AT 10)IBA 01/2018 - 12/2003
3	Antimycin AIBA 06/2012 - 10/2005
3	Phosphotransferases (Kinase)IBA 12/2010 - 01/2004
3	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2010 - 09/2006
3	lucifer yellowIBA 02/2009 - 01/2004
3	Protein Kinase CIBA 02/2009 - 10/2002
3	Connexin 43 (Connexin43)IBA 02/2009 - 01/2004
2	Adenine NucleotidesIBA 02/2024 - 01/2021
2	Urea (Carbamide)FDA LinkGeneric 06/2021 - 02/2021
2	NitrogenIBA 06/2021 - 02/2021
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2021 - 02/2013
2	AntioxidantsIBA 01/2019 - 09/2011
2	Sarcoglycans (beta Sarcoglycan)IBA 08/2015 - 09/2011
2	DystrophinIBA 08/2015 - 02/2013
2	NAD (NADH)IBA 02/2013 - 09/2011
2	HexokinaseIBA 05/2012 - 06/2010
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2011 - 10/2010
2	Cyclophilins (Cyclophilin)IBA 11/2010 - 06/2010
2	ATP Translocases Mitochondrial ADPIBA 11/2010 - 06/2010
2	Diazoxide (Hyperstat)FDA Link 11/2010 - 07/2002
2	SB 216763IBA 11/2010 - 08/2006
2	Valsartan (Vals)FDA Link 01/2010 - 05/2003
2	Acetates (Acetic Acid Esters)FDA Link 01/2010 - 09/2007
2	EnkephalinsIBA 01/2010 - 09/2007
2	MAP-kinase-activated kinase 2IBA 09/2009 - 06/2003
2	Heptanol (1 Heptanol)IBA 09/2007 - 01/2004
2	BuffersIBA 10/2006 - 01/2004
2	p38 Mitogen-Activated Protein KinasesIBA 01/2004 - 08/2003
1	Tolvaptan FDA Link 03/2023
1	Vasopressins (Vasopressin)IBA 03/2023
1	Aquaporin 2IBA 03/2023
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 03/2023
1	EnzymesIBA 01/2023
1	AcidsIBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	PotassiumIBA 06/2021
1	Insulin (Novolin)FDA Link 06/2021
1	Hemoglobins (Hemoglobin)IBA 06/2021
1	CreatinineIBA 02/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 02/2021
1	LipidsIBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 12/2019
1	CanagliflozinIBA 07/2019
1	SodiumIBA 07/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2017
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Ku 0063794IBA 01/2017

Therapy/Procedure

4	Ligation 01/2018 - 05/2003
2	Oral Administration 02/2013 - 03/2010
2	Therapeutics 07/2012 - 03/2010
1	Nephrectomy 01/2017